Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novartis AG CEO Talks Medicinal Sales

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/83e6a9d5-1c77-4535-aafc-b15b00ea962e/transcript

Scott Brothers Global Co-founders and CEOs Jonathan & Drew Scott, HGTV’s “Property Brothers,” discuss their new show, moving ‘in the wrong direction’ on affordability, and how AI can help developers. They sit down with Romaine Bostick for “The Close.”

Scott Brothers Global Co-founders and CEOs Jonathan &amp; Drew Scott, HGTV&rsquo;s &ldquo;Property Brothers,&rdquo; discuss their new show, moving &lsquo;in the wrong direction&rsquo; on affordability, and how AI can help developers. They sit down with Romaine Bostick for &ldquo;The Close.&rdquo;

Property Brothers Talks Housing Affordability, New Show

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/dded7944-cc0c-45c5-87b1-b410017fe5bc/transcript

IBM CEO Arvind Krishna discusses IBM's $11 billion acquisition of Confluent. Krishna also spoke about the impact of AI, his expectation for IBM to pursue more AI deals, the regulatory environment for those deals, and how AI is a tailwind for the company, causing no net decrease in workers. Krishna spoke with Bloomberg's Caroline Hyde.

IBM CEO Arvind Krishna discusses IBM's $11 billion acquisition of Confluent. Krishna also spoke about the impact of AI, his expectation for IBM to pursue more AI deals, the regulatory environment for those deals, and how AI is a tailwind for the company, causing no net decrease in workers. Krishna spoke with Bloomberg's Caroline Hyde.

IBM CEO Talks Confluent Acquisition and AI Impact

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cdff6cb1-6d7c-470b-bb68-b410011ffa7f/transcript

Strategas Research Partners Chairman and CEO Jason Trennert discusses his book, the purpose of the financial services industry, the potential challenge of private credit to the future, and the effect of geopolitical risk. Trennert spoke with Bloomberg's Tom Keene and Paul Sweeney.

Strategas Research Partners Chairman and CEO Jason Trennert discusses his book, the purpose of the financial services industry, the potential challenge of private credit to the future, and the effect of geopolitical risk. Trennert spoke with Bloomberg's Tom Keene and Paul Sweeney.

Strategas Research Partners CEO Talks Financial Services

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/be1c4553-295e-4097-a776-b410011dc697/transcript

Novartis AG CEO Talks Medicinal Sales

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips